Mutual Fund Ownership
Ownership as on: Sat, 20 Apr, 2024

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)313.70
% of AUM4.40%

SBI Healthcare Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)110.72
% of AUM4.22%

Mirae Asset Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)91.68
% of AUM4.10%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)25.12
% of AUM3.59%

SBI Magnum Global Fund Regular Growth

NA
Equity
Amount Invested (Cr.)202.98
% of AUM3.23%

FAQs about Gland Pharma share price

Gland Pharma is trading at 1757.00 as on Fri Apr 19 2024 09:59:43. This is -0.27% lower as compared to its previous closing price of 1761.75.

The market capitalization of Gland Pharma is 28939.64 Cr as on Fri Apr 19 2024 09:59:43.

The average broker rating on Gland Pharma is Hold. The breakup of analyst rating is given below -

  • 4 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Gland Pharma is 2195.75 whereas the 52 wk low is 861.50

Gland Pharma can be analyzed on the following key metrics -

  • TTM P/E: 48.12
  • Sector P/E: 30.14
  • Dividend Yield: 0.00%
  • D/E ratio: -

Gland Pharma reported a net profit of 781.04 Cr in 2023.

Recommended For You
Trending Stocks
7,107.00+217.75(3.16%)
2,082.90+58.75(2.90%)
1,531.30+36.70(2.46%)
1,450.00-17.65 (-1.20%)
2,437.10-25.65 (-1.04%)
HomeMarketsPremiumFor youGet App